Where global leaders learn how AI shapes business, technology and society
Michael Baker International has appointed 35-year technology veteran Stefano Esposito as Chief Product Officer of its GovTech vertical, tasked with building AI-native products for government modern...
Ambience Healthcare introduced a multi-domain AI platform covering care, revenue, and research, building on its documentation tools with expanded workflow capabilities.
Skild AI has acquired Zebra Technologies' robotics arm — the former Fetch Robotics — combining a foundation-model "brain" with a production-grade orchestration platform to go after full-warehouse a...
Cadence has completed its autonomous chip design stack with three AI Super Agents and a unified orchestrator — marking the clearest shift yet from AI copilots to agentic EDA.
Mount Sinai will deploy SOPHiA GENETICS’ AI platform to improve genomic testing, reduce analysis time, and scale cancer diagnostics workflows.
"We just reset our productivity to $2 billion over the next three years."
"Our customers want smarter, more efficient ways to manage expenses."
Medline will pilot Symbotic’s AI-powered warehouse system in 2027, marking the first use of the retail-proven technology in healthcare supply chains.
AI data centers now operate on weeks-long timelines and hour-level delivery windows, forcing logistics to shift from efficiency to execution.
Silicon Valley is walking away from MCP for the same reason financial services are adopting it.
"AI does not create value in isolation; its utility is given by human ingenuity."
The assistant maintains context across sessions. A workflow does not have to be rebuilt each time a creator returns to a project.
Uber’s AI coding push scaled faster than expected, exhausting its budget within months as token-based costs surged.
Ford said Doug Field will leave next month as it combines EV, software, and manufacturing into one unit to streamline development and in-house systems.
As healthcare leaders chase bigger LLMs, revenue cycle teams are achieving 30% denial reduction by narrowing AI scope and adding rigorous governance layers.
"As commerce becomes more agent-powered, trust becomes the defining factor."
Eli Lilly will acquire CrossBridge Bio for up to $300 million as it expands its ADC pipeline alongside investments in AI-driven drug discovery.
Valo Health appoints Chris Anagnostopoulos as Chief Causal AI Officer to scale its human data platform and improve drug discovery outcomes.
"As Autodesk prepares for its next chapter of growth, AI is reshaping how enterprises operate, and we are moving proactively to lead in that moment."
Novo Nordisk partners with OpenAI to apply AI across drug discovery, manufacturing, and operations, with full deployment planned by the end of 2026.